Profund Advisors LLC trimmed its holdings in shares of Xencor, Inc. (NASDAQ:XNCR – Free Report) by 12.6% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 21,541 shares of the biopharmaceutical company’s stock after selling 3,105 shares during the […]
Knight Therapeutics Announces Launch of Minjuvi® in Brazil lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
Xencor's (XNCR) Neutral Rating Reiterated at Piper Sandler themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Xencor (NASDAQ:XNCR – Get Free Report) released its quarterly earnings data on Tuesday. The biopharmaceutical company reported ($0.31) earnings per share for the quarter, missing the consensus estimate of $0.36 by ($0.67), Briefing.com reports. Xencor had a negative net margin of 81.94% and a negative return on equity of 17.26%. The company had revenue of […]
Piper Sandler Reaffirms Neutral Rating for Xencor (NASDAQ:XNCR) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.